Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Hutchmed (HCM) Regulatory News

Date Source Headline
23rd May 2025 7:00 am RNS-R HUTCHMED Highlights Data to be Presented at ASCO
13th May 2025 11:45 am RNS AGM held on May 13, 2025 – Poll Results
24th Apr 2025 7:00 am RNS-R HUTCHMED - Data to be Presented at AACR 2025
22nd Apr 2025 7:00 am RNS-R HUTCHMED Completes Enrollment of Phase II Study
7th Apr 2025 9:30 am RNS 2024 Annual Report and Notice of AGM
31st Mar 2025 10:30 am RNS Extraordinary General Meeting – Poll Results
21st Mar 2025 10:00 am RNS-R NMPA Conditional Approval for TAZVERIK®
20th Mar 2025 9:30 am RNS Retirement of Independent Non-executive Directors
20th Mar 2025 7:00 am RNS-R HUTCHMED Highlights Savolitinib SAVANNAH Phase II
19th Mar 2025 1:45 pm RNS-R Publication of Form 20-F
19th Mar 2025 11:00 am RNS 2024 Final Results and Business Updates
19th Mar 2025 7:00 am RNS-R Phase II/III Study of Fruquintinib and Sintilimab
14th Mar 2025 9:30 am RNS Adoption of the 2025 Long Term Incentive Plan
14th Mar 2025 9:30 am RNS Vesting of awards under Long Term Incentive Plan
13th Mar 2025 9:30 am RNS Notice of Extraordinary General Meeting
6th Mar 2025 10:00 am RNS-R Completed Enrollment of Phase II Study
5th Mar 2025 10:00 am RNS Directorate Change
3rd Mar 2025 7:00 am RNS Overseas Regulatory Announcement
28th Feb 2025 3:00 pm RNS Overseas Regulatory Announcement
19th Feb 2025 8:30 am RNS Notice of Results
28th Jan 2025 9:00 am RNS Overseas Regulatory Announcement
14th Jan 2025 7:00 am RNS-R Full Approval for ORPATHYS in China
2nd Jan 2025 7:00 am RNS Overseas Regulatory Announcement
2nd Jan 2025 7:00 am RNS US$608m Divestment of Non-Core Joint Venture
31st Dec 2024 8:30 am RNS Appointment of Joint Corporate Broker
30th Dec 2024 8:30 am RNS Blocklisting Six Monthly Return
29th Nov 2024 8:30 am RNS Total Voting Rights
20th Nov 2024 9:30 am RNS Appointment of Independent Non-executive Director
31st Oct 2024 8:30 am RNS Total Voting Rights
21st Oct 2024 9:30 am RNS Vesting of awards under the LTIP
16th Oct 2024 7:00 am RNS SAVANNAH: clinically meaningful response rate
24th Sep 2024 8:00 am RNS Japan Approval for FRUZAQLA
30th Aug 2024 9:30 am RNS Total Voting Rights
30th Aug 2024 7:00 am RNS Update on Fruquintinib for Gastric Cancer in China
22nd Aug 2024 9:30 am RNS Standard form for notification of major holdings
6th Aug 2024 10:00 am RNS LTIP and Share Option Scheme
31st Jul 2024 12:00 pm RNS 2024 Interim Results and Business Updates
28th Jun 2024 9:30 am RNS Total Voting Rights
28th Jun 2024 9:30 am RNS Blocklisting Six Monthly Return
26th Jun 2024 9:30 am RNS HUTCHMED to Announce 2024 HY Financial Results
FTSE 100 Latest
Value8,716.45
Change-9.56